Skip to main content
Contact Us
Subscribe
E-Edition
87°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novamind Inc
(OP:
NVMDF
)
N/A
UNCHANGED
Last Price
Updated: 3:36 PM EDT, Jun 13, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novamind Inc
< Previous
1
2
3
Next >
Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies
December 16, 2021
Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics...
Via
Benzinga
Topics
Death
Exposures
Death
Novamind Opens Addiction Clinic In Utah, Establishing Substance Use Disorder Program
December 06, 2021
Novamind Inc. (OTCQB:NVMDF),...
Via
Benzinga
Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders
December 06, 2021
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the...
From
Novamind Inc.
Via
AccessWire
Topics
Death
Exposures
COVID-19
Death
Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders
December 02, 2021
Novamind Inc. (OTCQB:NVMDF) a mental health compan...
Via
Benzinga
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
December 02, 2021
TORONTO, ON / ACCESSWIRE / December 2, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will...
From
Novamind Inc.
Via
AccessWire
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
December 01, 2021
Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic model TORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc....
From
Novamind Inc.
Via
AccessWire
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
November 29, 2021
- Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice - Total revenue of $1,857,750, +113% when compared to same period last year - Total working capital of...
From
Novamind Inc.
Via
AccessWire
Novamind Unveils New Logo and Invests in Unified Brand
November 24, 2021
TORONTO, ON / ACCESSWIRE / November 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc
Via
AccessWire
Psychedelic Medicine: Major Health Providers Including Blue Cross Now Cover Ketamine Treatments
November 18, 2021
Four major health insurance providers recently approved psychedelic medicine company Novamind Inc. (CSE:
Via
Benzinga
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
November 16, 2021
TORONTO, ON / ACCESSWIRE / November 16, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness
November 15, 2021
TORONTO, ON / ACCESSWIRE / November 15, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will...
From
Novamind Ventures Inc.
Via
AccessWire
Novamind Enters New Lease Agreement Responding to Patient Demand
November 12, 2021
TORONTO, ON / ACCESSWIRE / November 12, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced...
From
Novamind Inc.
Via
AccessWire
Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others
November 11, 2021
Compass Pathways reported
Via
Talk Markets
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
November 10, 2021
Blue Cross added to list of insurance companies covering IV ketamine treatments at Novamind TORONTO, ON / ACCESSWIRE / November 10, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or...
From
Novamind Inc.
Via
AccessWire
Exposures
Product Safety
Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading
November 08, 2021
TORONTO, ON / ACCESSWIRE / November 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces...
From
Novamind Inc.
Via
AccessWire
Novamind Reports FY2021 Financial Results and Operating Highlights
November 05, 2021
- Industry-leading revenue, $6,069,247 in FY2021 - Total working capital of $9,680,431 to fund operations - Expanded network to six clinics and three clinical research sites - Contracted for eight...
From
Novamind Inc.
Via
AccessWire
Exposures
COVID-19
Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
November 04, 2021
Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat?
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
November 04, 2021
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
October 23, 2021
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last.
Via
Talk Markets
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
October 22, 2021
TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased...
From
Novamind Ventures Inc.
Via
AccessWire
Novamind Granted DEA Licenses for Psilocybin Research
October 13, 2021
Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substances TORONTO, ON / ACCESSWIRE / October 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or...
From
Novamind Inc.
Via
AccessWire
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program
October 11, 2021
The Week In Psychedelics
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
Novamind to Present at LD Micro and KCSA Conferences
October 08, 2021
TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Psychedelic Medicine For End-Of-Life And Palliative Care Patients: Novamind Launches Treatment Program
October 07, 2021
Novamind (Canadian: NM) (OTCQB:NVMDF), a company in the ps...
Via
Benzinga
Novamind Launches New Psychedelic Palliative Care Program
October 07, 2021
Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illness TORONTO, ON / ACCESSWIRE / October 7, 2021 / Novamind Inc....
From
Novamind Inc.
Via
AccessWire
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
The Week In Psychedelics:
Via
Benzinga
Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021
October 04, 2021
Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapy TORONTO, ON / ACCESSWIRE / October 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"...
From
Novamind Ventures Inc.
Via
AccessWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.